Guard Therapeutics International AB (publ) reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was SEK 39.92 million compared to SEK 18.98 million a year ago. Basic loss per share from continuing operations was SEK 4 compared to SEK 3 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.6 SEK | -0.67% | +2.78% | -17.32% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.32% | 27.35M | |
+1.77% | 42.75B | |
+47.70% | 41.61B | |
+12.24% | 41.34B | |
-8.83% | 26.59B | |
+7.44% | 25.49B | |
-23.01% | 18.12B | |
+30.56% | 12.24B | |
-1.82% | 11.76B | |
+8.35% | 11B |
- Stock Market
- Equities
- GUARD Stock
- News Guard Therapeutics International AB
- Guard Therapeutics International AB Reports Earnings Results for the First Quarter Ended March 31, 2023